信隆健康
(002105)
| 流通市值：20.52亿 | | | 总市值：20.73亿 |
| 流通股本：3.64亿 | | | 总股本：3.68亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 818,126,774.64 | 532,685,363.24 | 240,067,340.31 | 963,917,027.01 |
| 营业收入 | 818,126,774.64 | 532,685,363.24 | 240,067,340.31 | 963,917,027.01 |
| 二、营业总成本 | 817,159,759.69 | 523,988,489.87 | 235,752,167.46 | 965,435,220.28 |
| 营业成本 | 686,847,027.3 | 443,590,134.97 | 198,945,245.87 | 785,139,204.69 |
| 税金及附加 | 7,088,142.97 | 5,329,331.92 | 1,877,560.53 | 10,304,738.53 |
| 销售费用 | 25,925,254.39 | 16,655,256.67 | 6,273,454.66 | 28,875,732.71 |
| 管理费用 | 63,910,837.7 | 40,926,221.27 | 19,994,291.28 | 91,029,644.27 |
| 研发费用 | 30,119,353.86 | 19,373,691.88 | 9,820,715.71 | 45,583,241 |
| 财务费用 | 3,269,143.47 | -1,886,146.84 | -1,159,100.59 | 4,502,659.08 |
| 其中:利息费用 | 10,765,934.22 | 6,865,186.36 | 3,081,296.04 | 16,888,789.59 |
| 其中:利息收入 | 5,442,197.95 | 4,057,452.25 | 2,113,584.32 | 8,324,411.78 |
| 加:投资收益 | -3,462,353.23 | -2,375,643.27 | -1,181,183.53 | -627,491.49 |
| 资产处置收益 | 2,842,836.65 | 2,844,072.04 | -236,011.88 | -87,807.9 |
| 资产减值损失(新) | - | - | - | -5,990,836.97 |
| 信用减值损失(新) | -919,253.3 | -2,602,845.97 | 530,355.05 | -498,160.18 |
| 其他收益 | 2,243,493.56 | 1,231,264.73 | 401,622.27 | 1,597,601.57 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,671,738.63 | 7,793,720.9 | 3,829,954.76 | -7,124,888.24 |
| 加:营业外收入 | 1,919,401.24 | 1,591,857.47 | 394,624.77 | 24,151,271.33 |
| 减:营业外支出 | 1,350,638.31 | 1,285,057.3 | 579,559.96 | 3,048,162.97 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 2,240,501.56 | 8,100,521.07 | 3,645,019.57 | 13,978,220.12 |
| 减:所得税费用 | 1,863,480.32 | 721,235.56 | 925,045.5 | -2,854,965.35 |
| 六、净利润 | 377,021.24 | 7,379,285.51 | 2,719,974.07 | 16,833,185.47 |
| 持续经营净利润 | 377,021.24 | 7,379,285.51 | 2,719,974.07 | 16,833,185.47 |
| 归属于母公司股东的净利润 | 837,649.51 | 6,527,977.36 | 2,457,102.84 | 21,702,672.34 |
| 少数股东损益 | -460,628.27 | 851,308.15 | 262,871.23 | -4,869,486.87 |
| (一)基本每股收益 | 0 | 0.02 | 0.01 | 0.06 |
| (二)稀释每股收益 | 0 | 0.02 | 0.01 | 0.06 |
| 八、其他综合收益 | -711,846.28 | -5,377,595.25 | 64,352.72 | -6,381,731.94 |
| 归属于母公司股东的其他综合收益 | -452,015.93 | -3,674,853.36 | 32,858.37 | -3,507,451.51 |
| 九、综合收益总额 | -334,825.04 | 2,001,690.26 | 2,784,326.79 | 10,451,453.53 |
| 归属于母公司股东的综合收益总额 | 385,633.58 | 2,853,124 | 2,489,961.21 | 18,195,220.83 |
| 归属于少数股东的综合收益总额 | -720,458.62 | -851,433.74 | 294,365.58 | -7,743,767.3 |
| 公告日期 | 2024-10-26 | 2024-08-24 | 2024-04-27 | 2024-04-24 |
| 审计意见(境内) | | | | 标准无保留意见 |